Labcorp Holdings Inc.
LH
$336.34
$3.531.06%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.35B | 14.14B | 13.95B | 13.77B | 13.48B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.35B | 14.14B | 13.95B | 13.77B | 13.48B |
| Cost of Revenue | 10.20B | 10.07B | 9.94B | 9.85B | 9.69B |
| Gross Profit | 4.14B | 4.08B | 4.01B | 3.92B | 3.79B |
| SG&A Expenses | 2.23B | 2.23B | 2.23B | 2.27B | 2.29B |
| Depreciation & Amortization | 295.80M | 286.00M | 280.00M | 277.80M | 272.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.73B | 12.58B | 12.45B | 12.40B | 12.25B |
| Operating Income | 1.62B | 1.56B | 1.51B | 1.36B | 1.23B |
| Income Before Tax | 1.23B | 1.15B | 1.11B | 1.10B | 974.30M |
| Income Tax Expenses | 230.20M | 209.30M | 229.80M | 244.30M | 209.80M |
| Earnings from Continuing Operations | 1.00K | 942.70 | 877.70 | 856.40 | 764.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.20M | -1.20M | -1.20M | -1.20M | -1.10M |
| Net Income | 1.00B | 941.50M | 876.50M | 855.20M | 763.40M |
| EBIT | 1.62B | 1.56B | 1.51B | 1.36B | 1.23B |
| EBITDA | 2.32B | 2.25B | 2.19B | 2.05B | 1.91B |
| EPS Basic | 12.17 | 11.37 | 10.54 | 10.26 | 9.13 |
| Normalized Basic EPS | 10.47 | 9.78 | 9.41 | 8.52 | 7.67 |
| EPS Diluted | 12.08 | 11.28 | 10.45 | 10.19 | 9.07 |
| Normalized Diluted EPS | 10.40 | 9.71 | 9.34 | 8.46 | 7.62 |
| Average Basic Shares Outstanding | 329.60M | 331.30M | 332.60M | 333.70M | 334.60M |
| Average Diluted Shares Outstanding | 331.80M | 333.70M | 335.10M | 336.10M | 336.80M |
| Dividend Per Share | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 |
| Payout Ratio | 23.86% | 25.52% | 27.46% | 28.24% | 31.71% |